Prabhakar Munkampalli is a seasoned professional with over 19 years of experience in the pharmaceutical and biotechnology sectors, including more than 14 years specializing in Clinical SAS programming. Currently serving as a Manager of Statistical Programming at Parexel, Prabhakar operates in a dual capacity as...
Prabhakar Munkampalli is a seasoned professional with over 19 years of experience in the pharmaceutical and biotechnology sectors, including more than 14 years specializing in Clinical SAS programming. Currently serving as a Manager of Statistical Programming at Parexel, Prabhakar operates in a dual capacity as both a Functional Line Manager and Operational Manager, demonstrating his versatility and depth of expertise in the field.
In his role as Functional Line Manager, Prabhakar acts as a pivotal point of contact for multiple products, providing essential technical oversight and ensuring the highest quality standards for all deliverables to sponsors. His extensive knowledge in clinical trials, particularly within oncology, allows him to guide Study Lead Programmers effectively, ensuring that project objectives are met with precision and adherence to Good Clinical Practice (GCP) guidelines. Prabhakar's ability to manage teams spread across various geographic locations has been instrumental in the successful delivery of numerous projects, where he balances operational efficiency with strategic oversight.
His proficiency in statistical programming, validation processes, and molecular biology further enhances his capability to lead complex projects in clinical research. Prabhakar's commitment to quality and operational excellence not only fosters a collaborative environment among his team members but also builds strong relationships with sponsors, ensuring that all project milestones are achieved on time and within budget. With a robust foundation in SAS programming and a keen understanding of clinical protocols, Prabhakar Munkampalli continues to make significant contributions to the advancement of clinical research at Parexel.
